Zidovudine and Lamivudine Given Once Versus Twice Daily

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2002

Conditions
HIV Infections
Interventions
DRUG

Lamivudine/Zidovudine

Trial Locations (20)

10029

Metropolitan Hosp Ctr, New York

13210

SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse

19140

Temple University School of Medicine, Philadelphia

30306

Emory Univ Hosp / Pediatrics, Atlanta

32209

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville

39213

Univ of Mississippi Med Ctr, Jackson

60608

Mt Sinai Hosp Med Ctr / Dept of Pediatrics, Chicago

60612

Cook County Hosp, Chicago

77030

Texas Children's Hosp / Baylor Univ, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

92103

Univ of California, San Diego, San Diego

117948111

State Univ of New York at Stony Brook, Stony Brook

191044318

Children's Hosp of Philadelphia, Philadelphia

381052794

Saint Jude Children's Research Hosp of Memphis, Memphis

606143394

Chicago Children's Memorial Hosp, Chicago

701122699

Tulane Univ / Charity Hosp of New Orleans, New Orleans

021155724

Children's Hosp of Boston, Boston

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

07503

St Joseph's Hosp & Med Center, Paterson

009365067

Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00014014 - Zidovudine and Lamivudine Given Once Versus Twice Daily | Biotech Hunter | Biotech Hunter